Search Results
244 results found for "Tectonic Therapeutic"
- 📰 GPCR Weekly News, December 4 to 10, 2023
Muscarinic Agonist Candidates in Phase 1 Clinical Studies AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics
- HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G 1/S cycle
modulating autophagy and the CDKN1B-CDK2-CCNE1-E2F1 axis and indicate that ARRB1 may be a potential therapeutic
- 📰 GPCR Weekly News, November 6 to November 12, 2023
Jefferies Healthcare Conference in London Sosei Heptares and Kallyope Nominate First GPCR Target for Therapeutic
- 📰 GPCR Weekly News, February 13 to 19, 2023
GPCR Binders, Drugs, and more Novel targets for potential therapeutic use in Diabetes mellitus.
- 📰 GPCR Weekly News, February 5 to 11, 2024
Fourth Quarter and Fiscal 2023 Financial Results and Provides Financial Expectations for 2024 Domain Therapeutics
- 📰 GPCR Weekly News, March 6 to 12, 2023
Domain Therapeutics was nominated for the Trophée de l'Innovation Technologique (Technological Innovation
- 📰 GPCR Weekly News, January 8 to 14, 2024
MCF7 breast cancer cells Reviews, GPCRs, and more The multifaceted functions of β-arrestins and their therapeutic
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
accurately reflect native biological processes and preclinical research can more reliably translate into therapeutic Trends in clinical success rates and therapeutic focus. Endosomal signaling of delta opioid receptors is an endogenous mechanism and therapeutic target for relief
- Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery
GPCR dimers are therefore emerging drug targets in different therapeutic areas including depression,
- 📰 GPCR Weekly News, April 24 to 30, 2023
GPCR Events, Meetings, and Webinars ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics
- 📰 GPCR Weekly News, December 18 to 31, 2023
Morgan Healthcare Conference Andrew Hopkins appointed CBE by HM King Charles III Voyager Therapeutics
- 📰 GPCR Weekly News, May 13 to 19, 2024
Mark your calendar for the GPCRs as Therapeutic Targets symposium on October 11th, 2024.
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
continue to propel our quest to unravel the complexities of GPCR signaling and pave the way for novel therapeutic
- 📰 GPCR Weekly News, April 8 to 14, 2024
Industry News Monash University retains its N° 2 global ranking for Pharmacy and Pharmacology Addex Therapeutics
- 📰 GPCR Weekly News, February 19 to 25, 2024
GPCR Binders, Drugs, and more Advances in structure-based drug design: The potential for precision therapeutics
- 📰 GPCR Weekly News
GPCRs in Neuroscience CGRP physiology, pharmacology, and therapeutic targets: Migraine and beyond.
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
Pharmacology & therapeutics, 89(2), 139–147. https://doi.org/10.1016/s0163-7258(00)00107-8
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
This scavenging function should be considered when evaluating the safety and therapeutic efficacy of
- Decoding β-Arrestins: from Structure to function
within distinct cell types or tissues, will undoubtedly provide valuable guidance for advancing such therapeutic
- Structural landscape of the Chemokine Receptor system
binding and receptor activation will pave the way for significant advancements in the development of therapeutics